Expanesthetics is the global leader in the search for new, improved inhaled general anesthetics. We are using our screening technology to transform this multi-billion dollar global market by identifying molecules that may have benefits over existing anesthetics with fewer unwanted effects.
Anesthesia providers continue to affirm the need for improvements in current anesthetic agents as demonstrated by our market research. In addition, market conditions such as changes in patient demographics, increased focus on improved surgical outcomes, and "pay-for-performance" have created ideal conditions for the development of new, improved anesthetic agents.
To our knowledge, no other company is making investments in R&D to develop the next generation of inhaled anesthetic agents.
As a potential added benefit of developing new anesthetic drugs to disruptively transform the anesthesia market, Expanesthetics is energized by the idea that these potential new drugs could also help alleviate suffering and promote prosperity around the world. If these new and better anesthetic drugs lower the cost to safely deliver anesthesia care, it could result in a long-term increase in surgical access for the estimated 5 billion people around the world who lack access to safe surgical and anesthesia care. That could in turn curb the $12.3 trillion productivity loss that the world is projected to suffer by 2030 due to lack of access to surgical and anesthesia care.
This overview video will give you a sense of perspective:
This introduction from our inventor, Dr. Robert Brosnan, will give you a sense of our opportunity, goal, and approach:
This video from The Lancet Commission on Global Surgery highlights the significant need for increased access to surgical and anesthesia care in the developing world. We hope to make an impact in addressing this challenge by developing new inhaled anesthetics with fewer side effects. Such drugs may reduce the infrastructure costs associated with anesthesia to such an extent billions more people around the world might gain access to surgical and anesthesia care.
This video from the World Federation of Societies of Anesthesiologists illustrates the anesthesia challenge many low-income countries are facing. These are the sorts of environments we believe the drugs we are developing could make a huge difference in accelerating the number of anesthesia providers who can be trained to safely administer general anesthesia.
Finally, the following video summarizes the global need for anesthesia and our vision for addressing it.
Learn about anesthesia by listening to NPR's 2017 Fresh Air interview of pediatric anesthesiologist Dr. Henry Jay Przybylo.
Discover how anesthesiologists are changing their use of inhaled general anesthetics in response to climate change in this NPR story from 2019.
Explore neurological findings about anesthesia in Wired's 2021 article about the brain during anesthesia.
Be surprised about anesthesia and plants on PBS' NOVA.
Experience the mystery of anesthesia on this classic episode of Radiolab.
Hear from a leading thinker on the nature of anesthesia and conciousness on Fresh Air with Dr. Emory Brown from 2011.
Be shocked about the state of global anesthesia and the lack of adequate pain relief on NPR's Goats and Soda blog.
Learn about the long history of anesthesia with the Wood Library-Museum of Anesthesiology's interactive timeline.